BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 15551289)

  • 1. Prevalence of hepatitis C virus infection in IgM-type monoclonal gammopathy of uncertain significance and Waldenström macroglobulinemia.
    Veneri D; Aqel H; Franchini M; Meneghini V; Krampera M
    Am J Hematol; 2004 Dec; 77(4):421. PubMed ID: 15551289
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of hepatitis C virus infection, Waldenström's macroglobulinemia, and monoclonal gammopathies.
    Silvestri F; Barillari G; Fanin R; Zaja F; Infanti L; Patriarca F; Baccarani M; Pipan C; Falasca E; Botta GA
    Blood; 1996 Aug; 88(3):1125-6. PubMed ID: 8704227
    [No Abstract]   [Full Text] [Related]  

  • 3. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients.
    Chauvet S; Bridoux F; Ecotière L; Javaugue V; Sirac C; Arnulf B; Thierry A; Quellard N; Milin S; Bender S; Goujon JM; Jaccard A; Fermand JP; Touchard G
    Am J Kidney Dis; 2015 Nov; 66(5):756-67. PubMed ID: 25987261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloidosis with IgM monoclonal gammopathies.
    Gertz MA; Kyle RA
    Semin Oncol; 2003 Apr; 30(2):325-8. PubMed ID: 12720162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
    Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
    Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?
    Gobbi PG; Baldini L; Broglia C; Goldaniga M; Comelli M; Morel P; Morra E; Cortelazzo S; Bettini R; Merlini G
    Clin Cancer Res; 2005 Mar; 11(5):1786-90. PubMed ID: 15756000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of monoclonal macroglobulinemia].
    Leporrier M
    Rev Prat; 1993 Feb; 43(3):298-301. PubMed ID: 8502959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraproteinemic neuropathy.
    Kwan JY
    Neurol Clin; 2007 Feb; 25(1):47-69. PubMed ID: 17324720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
    Schop RF; Van Wier SA; Xu R; Ghobrial I; Ahmann GJ; Greipp PR; Kyle RA; Dispenzieri A; Lacy MQ; Rajkumar SV; Gertz MA; Fonseca R
    Cancer Genet Cytogenet; 2006 Sep; 169(2):150-3. PubMed ID: 16938573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic aberrations in neuropathy associated with IgM monoclonal gammopathy.
    Eurelings M; Lokhorst HM; Notermans NC; Krijtenburg PJ; Kessel Bv; Eleveld MJ; Bloem A; Wokke JH; Poot M; Buijs A
    J Neurol Sci; 2007 Sep; 260(1-2):124-31. PubMed ID: 17543994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrobiotic xanthogranuloma associated with immunoglobulin m paraproteinemia in a patient with Waldenström macroglobulinemia.
    Balagula Y; Straus DJ; Pulitzer MP; Lacouture ME
    J Clin Oncol; 2011 Apr; 29(11):e305-7. PubMed ID: 21245419
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus infection and lymphoproliferative disorders.
    Andreone P; Gramenzi A; Cursaro C; Bernardi M
    Blood; 1995 Nov; 86(9):3610-1. PubMed ID: 7579472
    [No Abstract]   [Full Text] [Related]  

  • 13. Paraproteinemic neuropathies.
    Vital A
    Brain Pathol; 2001 Oct; 11(4):399-407. PubMed ID: 11556684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, specificity and functionality of anti-ganglioside antibodies in neuropathy associated with IgM monoclonal gammopathy.
    Stork AC; Jacobs BC; Tio-Gillen AP; Eurelings M; Jansen MD; van den Berg LH; Notermans NC; van der Pol WL
    J Neuroimmunol; 2014 Mar; 268(1-2):89-94. PubMed ID: 24529728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waldenström's macroglobulinemia in a 10-year stable IgG monoclonal gammopathy of undetermined significance.
    Iwanaga M; Yoshida Y; Tagawa M; Sekine I; Kamihira S; Tomonaga M
    Leuk Res; 2009 Jan; 33(1):193-5. PubMed ID: 18455789
    [No Abstract]   [Full Text] [Related]  

  • 16. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemia.
    Kyle RA; Benson J; Larson D; Therneau T; Dispenzieri A; Melton Iii LJ; Rajkumar SV
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):17-8. PubMed ID: 19362962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of monoclonal gammopathy in a general hospital and a university internal medicine department].
    Decaux O; Rodon P; Ruelland A; Estepa L; Leblay R; Grosbois B
    Rev Med Interne; 2007 Oct; 28(10):670-6. PubMed ID: 17566610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal gammopathies and hepatitis C virus infection.
    Mussini C; Ghini M; Mascia MT; Giovanardi P; Zanni G; Lattuada I; Moreali S; Longo G; Ferrari MG; Torelli G
    Blood; 1995 Feb; 85(4):1144-5. PubMed ID: 7849303
    [No Abstract]   [Full Text] [Related]  

  • 19. Human monoclonal macroglobulins with antibody activity.
    Stone MJ; McElroy YG; Pestronk A; Reynolds JL; Newman JT; Tong AW
    Semin Oncol; 2003 Apr; 30(2):318-24. PubMed ID: 12720161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders.
    Higgins L; Nasr SH; Said SM; Kapoor P; Dingli D; King RL; Rajkumar SV; Kyle RA; Kourelis T; Gertz MA; Dispenzieri A; Lacy MQ; Buadi FK; Ansell SM; Gonsalves WI; Thompson CA; Fervenza FC; Zand L; Hwa YL; Jevremovic D; Shi M; Leung N
    Clin J Am Soc Nephrol; 2018 Jul; 13(7):1037-1046. PubMed ID: 29848505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.